The biologics CDMO secondary packaging market size to record US$ 2.59 billion in 2025 and is projected to grow beyond US$ ...

President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result ...

All of the Texas Observer’s articles are available for free syndication for news sources under the following conditions: A ...

Using approved MS drug Copaxone during pregnancy or breastfeeding does not appear to raise the risk of problems for the child ...

Regeneron’s Eylea franchise remains resilient despite biosimilar competition. Read what makes REGN stock a Strong Buy despite ...

PA Groundhogs and the Center for Forensic Science Research & Education monitor for novel and emerging substances by testing ...

The growing interest in Mounjaro shows an increasing awareness of metabolic health, which is a positive trend. However, ...

If you’re looking into weight loss drugs, liraglutide has no doubt popped up. It’s a diabetes and weight loss medication sold ...

Alnylam Pharmaceuticals' shares rose more than 10% on Friday after the drugmaker secured U.S. approval for its heart disease drug, setting the stage for the 23-year-old biotech's next phase of growth.